A
AN2 Therapeutics
ANTX
2.55000
USD
-0.04
(-1.54%)
مغلق
حجم التداول
5,089
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
32,528,250
العنوان: AN2 Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.